361 related articles for article (PubMed ID: 30503373)
1. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms.
Suresh MK; Biswas R; Biswas L
Int J Med Microbiol; 2019 Jan; 309(1):1-12. PubMed ID: 30503373
[TBL] [Abstract][Full Text] [Related]
2. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of Staphylococcus aureus biofilms.
Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Lysostaphin functionalized silicon catheter for the prevention of Staphylococcus aureus biofilm.
Jayakumar J; Vinod V; Arumugam T; Sathy BN; Biswas L; Kumar VA; Biswas R
Int J Biol Macromol; 2024 Jan; 256(Pt 2):128547. PubMed ID: 38048926
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.
Drilling A; Morales S; Jardeleza C; Vreugde S; Speck P; Wormald PJ
Am J Rhinol Allergy; 2014; 28(1):3-11. PubMed ID: 24717868
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
7. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.
Drilling A; Morales S; Boase S; Jervis-Bardy J; James C; Jardeleza C; Tan NC; Cleland E; Speck P; Vreugde S; Wormald PJ
Int Forum Allergy Rhinol; 2014 Mar; 4(3):176-86. PubMed ID: 24449635
[TBL] [Abstract][Full Text] [Related]
9. Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation.
Kwiecinski J; Na M; Jarneborn A; Jacobsson G; Peetermans M; Verhamme P; Jin T
Appl Environ Microbiol; 2016 Jan; 82(1):394-401. PubMed ID: 26519394
[TBL] [Abstract][Full Text] [Related]
10. 5-aminolevulinic acid-mediated photodynamic therapy and its strain-dependent combined effect with antibiotics on Staphylococcus aureus biofilm.
Zhang QZ; Zhao KQ; Wu Y; Li XH; Yang C; Guo LM; Liu CH; Qu D; Zheng CQ
PLoS One; 2017; 12(3):e0174627. PubMed ID: 28358851
[TBL] [Abstract][Full Text] [Related]
11. Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies.
Raafat D; Otto M; Reppschläger K; Iqbal J; Holtfreter S
Trends Microbiol; 2019 Apr; 27(4):303-322. PubMed ID: 30665698
[TBL] [Abstract][Full Text] [Related]
12. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
[TBL] [Abstract][Full Text] [Related]
13. Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.
Hogan S; O'Gara JP; O'Neill E
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203484
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis of silver nanoparticles treated Staphylococcus aureus reveals potential targets for biofilm inhibition.
Singh N; Rajwade J; Paknikar KM
Colloids Surf B Biointerfaces; 2019 Mar; 175():487-497. PubMed ID: 30572157
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of biofilm infections using shock waves combined with antibiotic therapy.
Gnanadhas DP; Elango M; Janardhanraj S; Srinandan CS; Datey A; Strugnell RA; Gopalan J; Chakravortty D
Sci Rep; 2015 Dec; 5():17440. PubMed ID: 26658706
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus.
Morris J; Kelly N; Elliott L; Grant A; Wilkinson M; Hazratwala K; McEwen P
Surg Infect (Larchmt); 2019 Jan; 20(1):16-24. PubMed ID: 30207891
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Autolysin-Encoding Genes by Phage-Derived Lytic Proteins Inhibits Biofilm Formation in Staphylococcus aureus.
Fernández L; González S; Campelo AB; Martínez B; Rodríguez A; García P
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289031
[TBL] [Abstract][Full Text] [Related]
18. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
[TBL] [Abstract][Full Text] [Related]
19. Potential of bacteriophages as disinfectants to control of Staphylococcus aureus biofilms.
Song J; Ruan H; Chen L; Jin Y; Zheng J; Wu R; Sun D
BMC Microbiol; 2021 Feb; 21(1):57. PubMed ID: 33607940
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus biofilms: recent developments in biofilm dispersal.
Lister JL; Horswill AR
Front Cell Infect Microbiol; 2014; 4():178. PubMed ID: 25566513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
